High levels of TS in tumours have been associated with a poor response to TS-targeting agents in individuals with advanced lung cancer (Oguri et al, 2005; Kubota et al, 2009; Ozasa et al, 2009), although the biological relevance of TS in lung cancer has remained to be well established. Here, TYMS is linked to neoplasm.